Thursday, 23 January 2020 – Friday, 24 January 2020

Please click on the thumbnail image to play the presentation.

The epidemiology of paediatric MS
Professor Emmanuelle Waubant
Professor of Clinical Neurology and Pediatrics, Director of Regional Pediatric MS Clinic at UCSF,
San Francisco, CA, USA

The diagnosis of paediatric MS and excluding MS mimics
Dr Eluen Ann Yeh
Professor, Faculty of Medicine, University of Toronto; Director, Pediatric MS and Neuroinflammatory Disorders Program; Senior Associate Scientist, Division of Neuroscience and Mental Health, SickKids Research Institute; Staff Physician, Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada

Treating paediatric MS in the modern era
Dr Tanuja Chitnis
Director of the Partners Paediatric MS Center,
Massachusetts General Hospital, Boston, MA, USA

Women in the field of MS
Dr Ruth Dobson
Consultant Neurologist & Clinical Senior Lecturer, Wolfson Institute of Preventive Medicine,
Barts and The London School of Medicine and Dentistry, London, UK

How to optimise the use of disease-modifying therapies in relation to family planning and pregnancy
Professor Maria Pia Amato
Associate Professor of Neurology and Head of the Multiple Sclerosis Unit at the Department of NEUROFARBA,
University of Florence, Italy

Pregnancy outcomes in women with MS
Dr Kerstin Hellwig
Senior Consultant Neurologist at the Neuroimmunological Ward and Outpatient Clinic,
St. Josef Hospital, Bochum, Germany

Immunology of pregnancy and breastfeeding and its impact on MS
Professor Laura Airas
Professor of Neuroimmunology and Neurology Consultant,
University of Turku and Turku University Hospital, Finland

The pathology of secondary progressive MS
Professor Gabrielle De Luca
Associate Professor and Director of Clinical Neurosciences Undergraduate Education, Nuffield Department of Clinical Neurosciences,
John Radcliffe Hospital, Oxford, UK

Smoldering SPMS
Professor Gavin Giovannoni
Chair of Neurology, The Blizard Institute,
Barts and The London School of Medicine and Dentistry, London, UK

The changing perspective for the treatment of Progressive MS
Professor William Carroll
Clinical Professor of Neurology, University of Western Australia,
Consultant Neurologist at the Perron Institute, Perth, Australia

What does extended interval dosing tell us about the pathogenesis of MS?
Dr Susan Goelz
Scientific Director at Myelin Repair Foundation, Portland, OR, USA

Cognition dysfunction in progressive MS; how to manage it
Professor Dawn Langdon
Professor of Neuropsychology, Royal Holloway, University of London, UK

EBV-reactive cytotoxic T-cell therapy in MS
Professor Rajiv Khanna
Senior Principal Research Fellow (NH&MRC); Senior Scientist, QIMR Berghofer Medical Research Institute, Brisbane (Queensland) Australia

Leave a comment